Investment Performance Summary - The Large Cap Composite (Gross) achieved a quarterly return of 4.7% and a year-to-date return of 10.0% [3][10] - The Small Cap Composite (Gross) reported a quarterly return of 4.3% and a year-to-date return of 6.6% [16] - The Focus Composite (Gross) had a quarterly return of 3.8% and a year-to-date return of 7.3% [20] - The All Cap Composite (Gross) recorded a quarterly return of 5.7% and a year-to-date return of 9.9% [29] Company Contributions and Detractors - Medpace Holdings Inc. was a significant contributor to performance, with revenue growing at a mid-teens rate and operating earnings up 20% year-over-year [13][33] - Alphabet Inc. also contributed positively, benefiting from a favorable remedies decision in an antitrust case [14][34] - CarMax Inc. was identified as a material detractor, experiencing a 5% decline in retail volumes due to market volatility [15][19] Strategic Actions - Fiserv Inc. was purchased during the quarter, expected to generate over $5 billion in free cash flow, which will be used for share repurchases [11][31] - CBRE Group Inc. was sold to reallocate capital to more discounted businesses, despite its strong market position [12][32] - No new positions were added in the Small Cap and Focus strategies during the quarter [17][21] Market Conditions and Outlook - Stock price volatility was noted earlier in the year due to tariff-related concerns, leading to capital allocation towards stable value companies [8] - The overall market is perceived as not cheap, but the portfolios maintain a margin of safety with attractive price-to-value ratios [9][10] - The used car market remains volatile, but CarMax is expected to leverage its competitive advantages for long-term growth [15][19]

Hello readers! Passionate about technology, my focus will be on finding and analyzing companies that can play a relevant role in today's geopolitics, leverage their IP, and eventually, with time, become new leaders. Therefore, the investment style will correspond to growth companies with a bias on the mid-cap segment. The main sectors under study will be biotechnologies, computer chips, cloud technology, energy, and commodities. Special attention will be given to risks surrounding business cases, with a top ...

Group 1 - The article discusses the investment focus on growth companies, particularly in mid-cap segments, with an emphasis on sectors such as biotechnology, computer chips, cloud technology, energy, and commodities [1] - It highlights the importance of analyzing regulatory risks in both China and the US, which could impact companies like Illumina [1] - A systematic balance sheet analysis will be conducted to assess the financial health of growing businesses, as many may struggle with funding [1] Group 2 - The investment strategy prioritizes long-term capital appreciation over short-term speculation, indicating a preference for sustainable growth [1] - The article mentions the use of stress tests to evaluate the robustness of investment theses and the safety of business models [1] - The author expresses a commitment to providing extensive coverage on relevant themes and welcomes feedback to improve the analysis [1]